{"ticker": {"uuid": "8f58b094-e1e5-4804-8d60-73b4bfa37191", "symbol": "QTRX", "name": "Quanterix Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Quanterix wins coverage for Alzheimer\u2019s test (QTRX:NASDAQ)", "summary": "Quanterix Corporation saw a ~3% increase in premarket trading after announcing that its Alzheimer\u2019s test, LucentAD Complete, will be covered by Elevance Health\u2019s Anthem Blue Cross and Blue Shield health plans starting this month. This coverage is expected to expand access to the ", "url": "https://seekingalpha.com/news/4614001-quanterix-wins-coverage-alzheimers-test", "source_name": "Seeking Alpha", "published_at": "2026-07-15T12:40:16", "published_display": "15 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Anthem Blue Cross covers Quanterix Alzheimer\u2019s blood test", "summary": "Anthem Blue Cross and Blue Shield will now cover Quanterix Corporation's LucentAD Complete blood-based biomarker test for Alzheimer's disease for its 40 million members, effective July 1, 2026. This announcement led to a 5% increase in Quanterix's stock. The company also highligh", "url": "https://m.uk.investing.com/news/stock-market-news/anthem-blue-cross-covers-quanterix-alzheimers-blood-test-93CH-4770523?ampMode=1", "source_name": "Investing.com", "published_at": "2026-07-15T02:40:17", "published_display": "15 Jul 2026 02:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) Marks Key Milestones in Alzheimer's Testing Adv", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxONmNUYUhEeVBXNnlEWGRCTjdMYUhJMEFzbW1rR1ctUnNxN3hNZWtpVnNNQTJIUFY3S08xYU9fSjBJV2l0SVJTTmtCY3o0dHhNSFYxVGFFTzA1aGRqY0hhdkxGTi1MRDhaUGF2Q2pVeDVIRnFSbTY4NnJUN0gtSFBMbGZVRVJSbjg2YnFERW45M0FEQU1PNk9naHl5bnhrcFhnR0NpMTdwOFZpU3N0dHdKZzdBRk5RNVhtQk55d2xn?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-14T23:37:30+00:00", "published_display": "14 Jul 2026 23:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Advances Adoption of LucentAD Complete Blood Test", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/quanterix-advances-adoption-lucentad-complete-213410384.html", "source_name": "MT Newswires", "published_at": "2026-07-14T21:34:10+00:00", "published_display": "14 Jul 2026 21:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD\u00ae Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/anthem-blue-cross-blue-shield-202900532.html", "source_name": "Business Wire", "published_at": "2026-07-14T20:29:00+00:00", "published_display": "14 Jul 2026 20:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix test found preclinical Alzheimer\u2019s evidence in 20% of cognitively normal adults", "summary": "Quanterix announced that Anthem Blue Cross and Blue Shield will begin commercial coverage for its LucentAD\u00ae Complete blood test for Alzheimer's disease on July 1, 2026. This milestone, alongside a new peer-reviewed study and data presented at AAIC 2026, reinforces the clinical va", "url": "https://www.stocktitan.net/news/QTRX/anthem-blue-cross-and-blue-shield-establishes-commercial-coverage-2j56s64e9kal.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:13:55", "published_display": "14 Jul 2026 20:13", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Director Scott Mendel converts 8,073 RSUs at Quanterix (NASDAQ: QTRX)", "summary": "Quanterix director Scott Mendel converted 8,073 restricted stock units (RSUs) into common shares on July 8, 2026, as part of a routine vesting event. Following this transaction, he directly holds 24,056 common shares and 16,391 remaining RSUs. The converted RSUs were part of a 24", "url": "https://www.stocktitan.net/sec-filings/QTRX/form-4-quanterix-corp-insider-trading-activity-322868cb9286.html", "source_name": "Stock Titan", "published_at": "2026-07-10T20:40:01", "published_display": "10 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) director converts 8,073 RSUs, now holds 15,041 shares", "summary": "Quanterix Corp director Myla Lai-Goldman converted 8,073 restricted stock units (RSUs) into common shares, increasing her direct holdings to 15,041 shares. She still holds 16,391 RSUs which will convert into common stock on a one-for-one basis. These RSUs were part of a larger gr", "url": "https://www.stocktitan.net/sec-filings/QTRX/form-4-quanterix-corp-insider-trading-activity-af25698178ae.html", "source_name": "Stock Titan", "published_at": "2026-07-10T08:09:44", "published_display": "10 Jul 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) Stock Fair Value Falls After Analysts Cut Price Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNUFVwbC1rU0loeHBrMlpTNmZnX0NSNGw3SDBMTERHUUplYWlaMTQ5TWlzRURuX0IzQnItVWdQNU9UUUFNNHRwQ2ZOeE9OQ1A0b01Fd1Y4bU9LcW1EaDJlRF9ENndXbVpQTnFFZlJuZ1plX3RmV1MzdlBuZ0NiRUZnMmtqMXRZMURKNHRLTUQtYW1oeE1UX1AzcFpFdjE?oc=5", "source_name": "Market source", "published_at": "2026-07-09T23:21:35+00:00", "published_display": "09 Jul 2026 23:21", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Quanterix Corp For: 9 July By Investing.com", "summary": "This article announces the filing of Form 4 for Quanterix Corp on July 9th. It is a brief corporate news update from Investing.com, typical of filings news. The article also includes various market data like indices, commodities, and share prices, along with trending news and sto", "url": "https://ng.investing.com/news/stock-market-news/form-4-quanterix-corp-for-9-july-93CH-2594008", "source_name": "Investing.com Nigeria", "published_at": "2026-07-09T22:22:00", "published_display": "09 Jul 2026 22:22", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary", "summary": "Quanterix (QTRX) presented at the Goldman Sachs 47th Annual Global Healthcare Conference in 2026, where the company highlighted its strategic shift from research tools to clinical diagnostics, particularly in Alzheimer's. Key points included plans for FDA approval of a multi-mark", "url": "https://quartr.com/events/quanterix-qtrx-goldman-sachs-47th-annual-global-healthcare-conference-2026_36kffAsr", "source_name": "Quartr", "published_at": "2026-07-08T21:10:12", "published_display": "08 Jul 2026 21:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) Q1 2025 earnings summary", "summary": "Quanterix (QTRX) reported a Q1 2025 revenue of $30.3M, a 5% year-over-year decrease, with record consumables performance offset by softness in other segments, leading to a widened net loss of $20.5M. The company is prioritizing operational discipline and cost reductions to achiev", "url": "https://quartr.com/events/quanterix-qtrx-q1-2025_36kfzakF", "source_name": "Quartr", "published_at": "2026-07-08T21:10:12", "published_display": "08 Jul 2026 21:10", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QTRX: Recalibrated Expectations Will Shape Long Term Alzheimer\u2019s Blood Test Upside", "summary": "Analysts have adjusted their price targets for Quanterix (QTRX), leading to a lower but still supported valuation range, primarily due to recalibrated expectations regarding fair value, discount rates, revenue growth, profit margins, and future P/E multiples. While some analysts ", "url": "https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-qtrx/quanterix/sf6a9grg-biomarker-diagnostics-and-proteomics-will-shape-future-markets-aglx/updates/12-analysts-have-trimmed-their-quanterix-price-targets-by-a-few", "source_name": "Simply Wall Street", "published_at": "2026-07-08T20:17:26", "published_display": "08 Jul 2026 20:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) director gets 5,472-share stock grant for Q2 2026 board fees", "summary": "Quanterix (QTRX) director William P. Donnelly received a grant of 5,472 shares of common stock, valued at $4.34 per share, as compensation for his board service in Q2 2026, in lieu of cash fees. This transaction, categorized as a grant/award, increases his direct holdings to 160,", "url": "https://www.stocktitan.net/sec-filings/QTRX/form-4-quanterix-corp-insider-trading-activity-9d8619ac89fd.html", "source_name": "Stock Titan", "published_at": "2026-07-06T08:41:40", "published_display": "06 Jul 2026 08:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) director receives 3,456-share stock grant for board service", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPN1pJSGhoSU5yZ2xscUY3d1JRUThLNWNWM1V5UFh2WFNlSzNmUWxVaEx2T3JaSS1ROWhJamJXOUYzZW1HVy1IT2JSclQ3b0FzcndvUFowLVRHa1BGd09hbGNiX0MxMEZXaHA0WUx5bVNzQ0dwMXpDZ2dKeGlVY3VMYzdRTkpYS3JTbVlPM2tEZHNKWDRXQ2IxaEtZTndDdnpwNWtIUFp6ZUhHV0p1?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Corporation(NasdaqGM: QTRX) dropped from Russell 3000E Growth Benchmark", "summary": "Quanterix Corporation (NasdaqGM: QTRX) has been removed from the Russell 3000E Growth Benchmark. The article also provides recent news about the company, including management changes, quarterly earnings results, and presentations at financial conferences. It also includes financi", "url": "https://www.marketscreener.com/news/quanterix-corporation-nasdaqgm-qtrx-dropped-from-russell-3000e-growth-benchmark-ce7f5fdedc81f02c", "source_name": "www.marketscreener.com", "published_at": "2026-06-30T04:39:35", "published_display": "30 Jun 2026 04:39", "sentiment": "negative", "sentiment_pct": 32, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Corporation(NasdaqGM:QTRX) dropped from Russell Small Cap Comp Growth Benchmark", "summary": "Quanterix Corporation (NasdaqGM:QTRX) has been removed from the Russell Small Cap Comp Growth Benchmark, as announced on June 29, 2026. This news comes alongside several recent updates for the company, including presentations at a Goldman Sachs conference and changes to its execu", "url": "https://www.marketscreener.com/news/quanterix-corporation-nasdaqgm-qtrx-dropped-from-russell-small-cap-comp-growth-benchmark-ce7f5fdfdc89f222", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T21:10:21", "published_display": "29 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Corporation Actuals & Estimates (NASDAQ:QTRX)", "summary": "This article provides an overview of Quanterix Corporation (NASDAQ: QTRX) stock performance, financial actuals, and analyst estimates. It includes current stock price, recent performance trends, market capitalization, earnings estimates, revenue figures, and employee count. The a", "url": "https://www.tradingview.com/symbols/NASDAQ-QTRX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-29T04:10:21", "published_display": "29 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Quanterix Corporation \u2013 NASDAQ:QTRX", "summary": "This article displays the \"Enterprise value to EBITDA forward\" metric for Quanterix Corporation (NASDAQ: QTRX) on TradingView. It provides financial data for the company under the Health Technology sector. The content itself is an excerpt from a financial data platform, showcasin", "url": "https://www.tradingview.com/symbols/NASDAQ-QTRX/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T05:09:16", "published_display": "27 Jun 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Quanterix Corporation \u2013 NASDAQ:QTRX", "summary": "This article displays financial information for Quanterix Corporation (NASDAQ: QTRX), specifically its enterprise value to revenue forward metric. It's presented within a TradingView interface, showing market data from various providers like ICE Data Services and FactSet. The con", "url": "https://www.tradingview.com/symbols/NASDAQ-QTRX/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T09:11:45", "published_display": "26 Jun 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QTRX Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Quanterix Corporation (QTRX) stock, including analyst price targets and predictions for 2027. It details recent stock performance, financial metrics like EPS and revenue, and upcoming earnings dates. The article also answers frequently asked q", "url": "https://www.tradingview.com/symbols/NASDAQ-QTRX/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T08:39:19", "published_display": "26 Jun 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QTRX - Quanterix Corp Volatility & Greeks", "summary": "This article provides a detailed financial overview of Quanterix Corp (QTRX), including its stock performance, key financial metrics, and volatility data. It lists various ratios such as P/E, P/S, ROA, and highlights insider and institutional ownership, alongside short interest f", "url": "https://finviz.com/stock?t=QTRX&ty=ocv&p=d&r=ytd&ov=chain_date", "source_name": "Finviz", "published_at": "2026-06-26T05:10:55", "published_display": "26 Jun 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Stock Is Popping In Pre-Market: Here's Why", "summary": "Quanterix Corporation (NASDAQ: QTRX) stock surged 5.28% in pre-market trading after Securities and Exchange Commission filings revealed outgoing CFO Vandana Sriram vested and forfeited some restricted stock units. Jason Faessler officially assumed the CFO role, joining from Bruke", "url": "https://www.sahmcapital.com/news/content/quanterix-stock-is-popping-in-pre-market-heres-why-2026-06-24", "source_name": "Sahm", "published_at": "2026-06-25T15:39:37", "published_display": "25 Jun 2026 15:39", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Corp (QTRX) Valuation: PE, PB & Fair Value Analysis", "summary": "Quanterix Corp (QTRX) currently holds a valuation score of 7.38, placing it 163rd out of 203 in the Healthcare Equipment & Supplies industry. The company's P/E ratio is -1.83, which is significantly below its recent high and above its recent low. Key valuation metrics like P/B, P", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-qtrx/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-25T14:39:48", "published_display": "25 Jun 2026 14:39", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Corp sets out growth plans, shares trade on Nasdaq", "summary": "Quanterix Corp is gaining investor attention with its digital biomarker platform and recent operational milestones, with its shares trading on Nasdaq. The company focuses on developing ultra-sensitive digital biomarker assays based on its proprietary Simoa technology, targeting p", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/quanterix-corp-sets-out-growth-plans-shares-trade-on-nasdaq/69623587", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-25T12:41:48", "published_display": "25 Jun 2026 12:41", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Quanterix Corporation \u2013 NASDAQ:QTRX", "summary": "This article provides the \"Price to earnings forward\" metric for Quanterix Corporation (NASDAQ: QTRX). It indicates that the value and change percentages for this financial metric are made by humans and offers some context about the data providers. The main content focuses solely", "url": "https://www.tradingview.com/symbols/NASDAQ-QTRX/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-24T19:40:22", "published_display": "24 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) CFO adds stock as RSUs vest and shares withheld", "summary": "Quanterix CFO Vandana Sriram reported that 1,833 restricted stock units (RSUs) converted into common stock on June 15, 2026. Of these, 548 shares were withheld at $3.10 per share to cover tax obligations, which is a routine part of equity compensation. Following these transaction", "url": "https://www.stocktitan.net/sec-filings/QTRX/form-4-quanterix-corp-insider-trading-activity-ad0f6cb50692.html", "source_name": "Stock Titan", "published_at": "2026-06-24T14:39:48", "published_display": "24 Jun 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today", "summary": "Trinity Biotech (TRIB), Quanterix Corp. (QTRX), and Recon Technology (RCON) all experienced double-digit gains in after-hours trading. TRIB surged after launching Trinovium, a new subsidiary for liquid-cooling solutions for AI data centers. QTRX rose following the official appoin", "url": "https://stocktwits.com/news-articles/markets/equity/trib-qtrx-rcon-why-these-stocks-are-surging-after-hours-today/cZKUM3NR7O7", "source_name": "Stocktwits", "published_at": "2026-06-24T07:40:21", "published_display": "24 Jun 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Quanterix Corp For: 23 June", "summary": "This article provides an announcement regarding a Form 4 filing for Quanterix Corp on June 23. It also includes a standard disclaimer about the risks associated with trading financial instruments and cryptocurrencies, emphasizing market volatility and the importance of informed d", "url": "https://m.uk.investing.com/news/stock-market-news/form-4-quanterix-corp-for-23-june-93CH-4741296?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-24T01:40:25", "published_display": "24 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Quanterix Corp For: 23 June By Investing.com", "summary": "This article from Investing.com reports on a Form 4 filing for Quanterix Corp on June 23. It includes general stock market performance data for various indices, commodities, bonds, and individual stocks. The content indicates it's a routine financial news update on a company's SE", "url": "https://ca.investing.com/news/stock-market-news/form-4-quanterix-corp-for-23-june-93CH-4704252", "source_name": "Investing.com", "published_at": "2026-06-23T21:10:24", "published_display": "23 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/quanterix-corporation-reports-inducement-grants-200100131.html", "source_name": "Business Wire", "published_at": "2026-06-16T20:01:00+00:00", "published_display": "16 Jun 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Quanterix (QTRX) Chief Commercial Officer buys 3,500 shares in open-market trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNcEpBY1U5dkdJMzBQOUlLeGJvenBPTm44TWtRWkE1NG1LTXJrbUZ2RXFhMWFLU3ZzWHJOdE1ZSjFqMklmNkJzZDhTRmxqbWhGUGY0cGJQMmxYQzQxNkRSVF9kUmhsOTdZRk1ESTZteEJCUXdjOFROX1prM0lmTE53dl9HRU5Ia2tKRTNMMUpKNUtISEtkYl9WTnVVTGFnbnF3aHkyaWJoMzdUTXZu?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Names Jason Faessler as CFO", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/quanterix-names-jason-faessler-cfo-124406631.html", "source_name": "MT Newswires", "published_at": "2026-06-09T12:44:06+00:00", "published_display": "09 Jun 2026 12:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/quanterix-announces-appointment-jason-faessler-120300658.html", "source_name": "Business Wire", "published_at": "2026-06-09T12:03:00+00:00", "published_display": "09 Jun 2026 12:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "From Bruker to Quanterix: Jason Faessler takes over as CFO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNeWk5TXIzd1htQ3lMdlFxQ2x1aGZldko1dXFlLUk5VWdjaElPWXpoNGlYemhWV1FEVUpINWU1czQyVzNOR3NyUzNKM1dsOVJmZVdLc3Y3YU04dGo1X1JTc3hNVFZkSnBIdFRvajN2NU1DUGp0aXBRRlZFNl9Ob2hGZHF2WlNDRlMtTVZFb3RtZklScHNJREFKZG95NGFPWWoxNm9rV1F4UFJZU1NGLWZqLXNUb2VBS3lzTFZLLTFYRW0?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/quanterix-appoints-industry-veteran-geoff-120200262.html", "source_name": "Business Wire", "published_at": "2026-06-04T12:02:00+00:00", "published_display": "04 Jun 2026 12:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Former Quest exec Geoff Albrecht to lead Quanterix Alzheimer\u2019s diagnostics", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPNG5vaEI3MkhYN19hOVIxOFM1TjJKUG5BazkzQWFraW1MbmM1M3Z2dUMzbDQ3a25fNDJaaDBUa3RoZ0VkU25HZkJTRnFWdnhVTmlkZnptU0g5cmhqd0tjMFRGSDJaRVFTNm5qT25YZFFGb0ItV2U0RHBLcFFLcUROVjQ5VVNxNlp4VjVraHozTDQ1elIwd1plU09TdGxEdV8tU0IxWFpOU210ZmVSMTB2dG5FV0RETVYtRllSSg?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/quanterix-participate-goldman-sachs-47th-120100811.html", "source_name": "Business Wire", "published_at": "2026-06-03T12:01:00+00:00", "published_display": "03 Jun 2026 12:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix CEO to host June 9 fireside chat at Goldman Sachs healthcare event", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQV01DVkZTX0VnZW9Gc2pxaXBhVFg1b3RVWGc1NjQ2d09mZmJ0NWxaQ1FxMkloaXVGeGFzaXFnZERQTUpDenlBalAzY1RmbFFKdTllZ2Z6bGRxV1p2RncwOW5Ka1BvZkk1b2dReFl0YjRyZVN3UkZDRnpVZlVDaEtueXZXSzhnaXI2R1VPN1otblNTYlV5QldKWWpZTl95NVhEX3ItTkJIUjVPQV9SaWliZVVJWnpsbFpDaU93?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Quanterix COO Anthony Catalano gets 141,330 restricted stock units", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNZTd2VkFGdURFbTBsOHF2aG5jai1oR0pjUHNJb3A5MkhSeE1RQjZGUEJlVVFOSWViQlkwdDRFbzY0b25McURrWUhycDM2T0JadEpPTHRuY2FuS1RZQXdZVGZqYUlZcmZzSGxsRmtQQTVveDc0aXhoSnBHNzlHc0hhMkN6MHgtUl9KYmVpeVBnN0ZKdnM4Y2NoX3dUVkg3eGw3YkJ0ekxnWG9teWQwT20wV3pVYmlUbUJPaFBtR0RyYjA?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Quanterix Says CFO Vandana Sriram to Depart", "summary": "", "url": "https://finance.yahoo.com/news/quanterix-says-cfo-vandana-sriram-204740297.html", "source_name": "MT Newswires", "published_at": "2026-05-12T20:47:40+00:00", "published_display": "12 May 2026 20:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) Q1 Loss Of US$0.37 Per Share Reinforces Bearish Profitability Concerns", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix partners with Tempus AI on Alzheimer\u2019s blood test", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOb05IeXhsakRkNXBfS3RkbWdSWWUyQW1fZmVTMFA5QTdXY1ZLSVc5UWRYRnhEZG9hcDUxcWEyNDlYVE1nWXVZV1BFOHdKZUN6cHQwU1FUQUo5dzczVEJXaV9ZWUcwS3ZFZWZ3a1c0enhoSU5rSVV4NHRfa0hGemkwejlkRWZjZ3p1eDZ1dHQ3U2RqU0JhMzZSS25ucXVZTWFDUHQwTHNvblY5cTVNSUdQNTI0eFlDUQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QUANTERIX ($QTRX) Releases Q1 2026 Earnings, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxORUtXRmRnVm1RVlU4S3ZSMU5FSzJLUm16aktSVDNxS2xpeVFiZy1wR0VCVUZMZEd4TXdZbkNtY1lUYnNXTi1OLWZwOVlTa09sR0wzamJhT0pFRHY5eE40cFhVOEJnc0I3QXhGOHdzNUFZekNnREdBUTdPV2tmWEc3X0h5TmxhZldHX19JblZRNXVVUXlGRWdXMkZGYXBqUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Q1 2026 slides: $85M synergies offset organic decline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPOEJkRTk5Rm4yTUhxZVlzeGIwQlVjZ1pZMTI1bVZ0bFYxNkNSZFQ1eWpNcm8xcEpubFRHZTVfUC13TldCdzZaeFFjR1lpNllWMlRVQ0FyNlRyRzRVaDFhcjdjcUQ1NVlsN1k1QkNPd0RqR3RsMDRBbHVHQjBVUkRRM0NYN25fQmItQXM1Z2ZuYUhSYWFROUZQYWo5cXNiTTg3RER3NlR6RzV1cmtERnByNnZ5X1c3a0w5N0E?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "How The Quanterix (QTRX) Story Is Shifting After The Latest Fair Value Reset", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNNEVzOGltVGNrYS1jNVEydGtaeUZuMmQ4MERIVkFjaDQ3eG5ueUlSUlRJcS1XMnFOd1ZJUDc3eTJ0OTlIYnRQLXJ0dkdLSk1KMEZuUC1MTXVCMTlSYldBTU53YllEREJpaTJiMUZoNGdQRkM2Sk9HNGg4X1NEM21UNjRxMzZqVXA2d3NHNWJNMFFTaFNoS1RfQzRRc1premJ3TUJZ?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Quanterix: No Green Shoots (NASDAQ:QTRX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE91bFotNENIMXJkVXpYWjU4UEtOQ29iMDJ6Ukdzd2RrNXk3Qm1Zc1h0eU5pUTBGTDFzb2NicWxWUkFmZ0hIdlA5MmhYQjMyWndlZThWbjhGNlJoRGM2WUswZ0RLWUg2aEFybkhhWjhqYWxNLW5Z?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Quanterix Corporation (QTRX) Reports Q4 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNR1RobkZ4VWJ0a01ZZ3Nocml0dXVUczkybWZiclZ0bndhZXJPUVBOdVp2bmdtaFZEYjRiakVjcS14TG5wR0gwVEdwRGpMX2RqVUFCS0VGQXlNMmZoOURMVlJ4aFc2OVMxWHBWcVNwYVhSUEhtN0lPbjc3Z1RaR2VrOVJaVDJJSW5QYkhR?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Corporation (QTRX) Stock Price Today: $3.87", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1IVFMzaDVGR2d1VUU0QUplWTZPMmNtTDZiMTl1cFBvanlTQ215Z2FOMTVDOEgxVUxOckF6SWZzY1o5YTNzSlVQMmxQblk0Q3l6T0FZSUhFOA?oc=5", "source_name": "Gotrade", "published_at": "2026-01-13T01:05:31+00:00", "published_display": "13 Jan 2026 01:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Quanterix wins coverage for Alzheimer\u2019s test (QTRX:NASDAQ)", "summary": "Quanterix Corporation saw a ~3% increase in premarket trading after announcing that its Alzheimer\u2019s test, LucentAD Complete, will be covered by Elevance Health\u2019s Anthem Blue Cross and Blue Shield health plans starting this month. This coverage is expected to expand access to the ", "url": "https://seekingalpha.com/news/4614001-quanterix-wins-coverage-alzheimers-test", "source_name": "Seeking Alpha", "published_at": "2026-07-15T12:40:16", "published_display": "15 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Anthem Blue Cross covers Quanterix Alzheimer\u2019s blood test", "summary": "Anthem Blue Cross and Blue Shield will now cover Quanterix Corporation's LucentAD Complete blood-based biomarker test for Alzheimer's disease for its 40 million members, effective July 1, 2026. This announcement led to a 5% increase in Quanterix's stock. The company also highligh", "url": "https://m.uk.investing.com/news/stock-market-news/anthem-blue-cross-covers-quanterix-alzheimers-blood-test-93CH-4770523?ampMode=1", "source_name": "Investing.com", "published_at": "2026-07-15T02:40:17", "published_display": "15 Jul 2026 02:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) Marks Key Milestones in Alzheimer's Testing Adv", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxONmNUYUhEeVBXNnlEWGRCTjdMYUhJMEFzbW1rR1ctUnNxN3hNZWtpVnNNQTJIUFY3S08xYU9fSjBJV2l0SVJTTmtCY3o0dHhNSFYxVGFFTzA1aGRqY0hhdkxGTi1MRDhaUGF2Q2pVeDVIRnFSbTY4NnJUN0gtSFBMbGZVRVJSbjg2YnFERW45M0FEQU1PNk9naHl5bnhrcFhnR0NpMTdwOFZpU3N0dHdKZzdBRk5RNVhtQk55d2xn?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-14T23:37:30+00:00", "published_display": "14 Jul 2026 23:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Advances Adoption of LucentAD Complete Blood Test", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/quanterix-advances-adoption-lucentad-complete-213410384.html", "source_name": "MT Newswires", "published_at": "2026-07-14T21:34:10+00:00", "published_display": "14 Jul 2026 21:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD\u00ae Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/anthem-blue-cross-blue-shield-202900532.html", "source_name": "Business Wire", "published_at": "2026-07-14T20:29:00+00:00", "published_display": "14 Jul 2026 20:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix test found preclinical Alzheimer\u2019s evidence in 20% of cognitively normal adults", "summary": "Quanterix announced that Anthem Blue Cross and Blue Shield will begin commercial coverage for its LucentAD\u00ae Complete blood test for Alzheimer's disease on July 1, 2026. This milestone, alongside a new peer-reviewed study and data presented at AAIC 2026, reinforces the clinical va", "url": "https://www.stocktitan.net/news/QTRX/anthem-blue-cross-and-blue-shield-establishes-commercial-coverage-2j56s64e9kal.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:13:55", "published_display": "14 Jul 2026 20:13", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Scott Mendel converts 8,073 RSUs at Quanterix (NASDAQ: QTRX)", "summary": "Quanterix director Scott Mendel converted 8,073 restricted stock units (RSUs) into common shares on July 8, 2026, as part of a routine vesting event. Following this transaction, he directly holds 24,056 common shares and 16,391 remaining RSUs. The converted RSUs were part of a 24", "url": "https://www.stocktitan.net/sec-filings/QTRX/form-4-quanterix-corp-insider-trading-activity-322868cb9286.html", "source_name": "Stock Titan", "published_at": "2026-07-10T20:40:01", "published_display": "10 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) director converts 8,073 RSUs, now holds 15,041 shares", "summary": "Quanterix Corp director Myla Lai-Goldman converted 8,073 restricted stock units (RSUs) into common shares, increasing her direct holdings to 15,041 shares. She still holds 16,391 RSUs which will convert into common stock on a one-for-one basis. These RSUs were part of a larger gr", "url": "https://www.stocktitan.net/sec-filings/QTRX/form-4-quanterix-corp-insider-trading-activity-af25698178ae.html", "source_name": "Stock Titan", "published_at": "2026-07-10T08:09:44", "published_display": "10 Jul 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) Stock Fair Value Falls After Analysts Cut Price Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNUFVwbC1rU0loeHBrMlpTNmZnX0NSNGw3SDBMTERHUUplYWlaMTQ5TWlzRURuX0IzQnItVWdQNU9UUUFNNHRwQ2ZOeE9OQ1A0b01Fd1Y4bU9LcW1EaDJlRF9ENndXbVpQTnFFZlJuZ1plX3RmV1MzdlBuZ0NiRUZnMmtqMXRZMURKNHRLTUQtYW1oeE1UX1AzcFpFdjE?oc=5", "source_name": "Market source", "published_at": "2026-07-09T23:21:35+00:00", "published_display": "09 Jul 2026 23:21", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Quanterix Corp For: 9 July By Investing.com", "summary": "This article announces the filing of Form 4 for Quanterix Corp on July 9th. It is a brief corporate news update from Investing.com, typical of filings news. The article also includes various market data like indices, commodities, and share prices, along with trending news and sto", "url": "https://ng.investing.com/news/stock-market-news/form-4-quanterix-corp-for-9-july-93CH-2594008", "source_name": "Investing.com Nigeria", "published_at": "2026-07-09T22:22:00", "published_display": "09 Jul 2026 22:22", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary", "summary": "Quanterix (QTRX) presented at the Goldman Sachs 47th Annual Global Healthcare Conference in 2026, where the company highlighted its strategic shift from research tools to clinical diagnostics, particularly in Alzheimer's. Key points included plans for FDA approval of a multi-mark", "url": "https://quartr.com/events/quanterix-qtrx-goldman-sachs-47th-annual-global-healthcare-conference-2026_36kffAsr", "source_name": "Quartr", "published_at": "2026-07-08T21:10:12", "published_display": "08 Jul 2026 21:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) Q1 2025 earnings summary", "summary": "Quanterix (QTRX) reported a Q1 2025 revenue of $30.3M, a 5% year-over-year decrease, with record consumables performance offset by softness in other segments, leading to a widened net loss of $20.5M. The company is prioritizing operational discipline and cost reductions to achiev", "url": "https://quartr.com/events/quanterix-qtrx-q1-2025_36kfzakF", "source_name": "Quartr", "published_at": "2026-07-08T21:10:12", "published_display": "08 Jul 2026 21:10", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QTRX: Recalibrated Expectations Will Shape Long Term Alzheimer\u2019s Blood Test Upside", "summary": "Analysts have adjusted their price targets for Quanterix (QTRX), leading to a lower but still supported valuation range, primarily due to recalibrated expectations regarding fair value, discount rates, revenue growth, profit margins, and future P/E multiples. While some analysts ", "url": "https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-qtrx/quanterix/sf6a9grg-biomarker-diagnostics-and-proteomics-will-shape-future-markets-aglx/updates/12-analysts-have-trimmed-their-quanterix-price-targets-by-a-few", "source_name": "Simply Wall Street", "published_at": "2026-07-08T20:17:26", "published_display": "08 Jul 2026 20:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) director gets 5,472-share stock grant for Q2 2026 board fees", "summary": "Quanterix (QTRX) director William P. Donnelly received a grant of 5,472 shares of common stock, valued at $4.34 per share, as compensation for his board service in Q2 2026, in lieu of cash fees. This transaction, categorized as a grant/award, increases his direct holdings to 160,", "url": "https://www.stocktitan.net/sec-filings/QTRX/form-4-quanterix-corp-insider-trading-activity-9d8619ac89fd.html", "source_name": "Stock Titan", "published_at": "2026-07-06T08:41:40", "published_display": "06 Jul 2026 08:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) director receives 3,456-share stock grant for board service", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPN1pJSGhoSU5yZ2xscUY3d1JRUThLNWNWM1V5UFh2WFNlSzNmUWxVaEx2T3JaSS1ROWhJamJXOUYzZW1HVy1IT2JSclQ3b0FzcndvUFowLVRHa1BGd09hbGNiX0MxMEZXaHA0WUx5bVNzQ0dwMXpDZ2dKeGlVY3VMYzdRTkpYS3JTbVlPM2tEZHNKWDRXQ2IxaEtZTndDdnpwNWtIUFp6ZUhHV0p1?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Corporation(NasdaqGM: QTRX) dropped from Russell 3000E Growth Benchmark", "summary": "Quanterix Corporation (NasdaqGM: QTRX) has been removed from the Russell 3000E Growth Benchmark. The article also provides recent news about the company, including management changes, quarterly earnings results, and presentations at financial conferences. It also includes financi", "url": "https://www.marketscreener.com/news/quanterix-corporation-nasdaqgm-qtrx-dropped-from-russell-3000e-growth-benchmark-ce7f5fdedc81f02c", "source_name": "www.marketscreener.com", "published_at": "2026-06-30T04:39:35", "published_display": "30 Jun 2026 04:39", "sentiment": "negative", "sentiment_pct": 32, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Corporation(NasdaqGM:QTRX) dropped from Russell Small Cap Comp Growth Benchmark", "summary": "Quanterix Corporation (NasdaqGM:QTRX) has been removed from the Russell Small Cap Comp Growth Benchmark, as announced on June 29, 2026. This news comes alongside several recent updates for the company, including presentations at a Goldman Sachs conference and changes to its execu", "url": "https://www.marketscreener.com/news/quanterix-corporation-nasdaqgm-qtrx-dropped-from-russell-small-cap-comp-growth-benchmark-ce7f5fdfdc89f222", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T21:10:21", "published_display": "29 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Corporation Actuals & Estimates (NASDAQ:QTRX)", "summary": "This article provides an overview of Quanterix Corporation (NASDAQ: QTRX) stock performance, financial actuals, and analyst estimates. It includes current stock price, recent performance trends, market capitalization, earnings estimates, revenue figures, and employee count. The a", "url": "https://www.tradingview.com/symbols/NASDAQ-QTRX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-29T04:10:21", "published_display": "29 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Quanterix Corporation \u2013 NASDAQ:QTRX", "summary": "This article displays the \"Enterprise value to EBITDA forward\" metric for Quanterix Corporation (NASDAQ: QTRX) on TradingView. It provides financial data for the company under the Health Technology sector. The content itself is an excerpt from a financial data platform, showcasin", "url": "https://www.tradingview.com/symbols/NASDAQ-QTRX/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T05:09:16", "published_display": "27 Jun 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Quanterix Corporation \u2013 NASDAQ:QTRX", "summary": "This article displays financial information for Quanterix Corporation (NASDAQ: QTRX), specifically its enterprise value to revenue forward metric. It's presented within a TradingView interface, showing market data from various providers like ICE Data Services and FactSet. The con", "url": "https://www.tradingview.com/symbols/NASDAQ-QTRX/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T09:11:45", "published_display": "26 Jun 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QTRX Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Quanterix Corporation (QTRX) stock, including analyst price targets and predictions for 2027. It details recent stock performance, financial metrics like EPS and revenue, and upcoming earnings dates. The article also answers frequently asked q", "url": "https://www.tradingview.com/symbols/NASDAQ-QTRX/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T08:39:19", "published_display": "26 Jun 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QTRX - Quanterix Corp Volatility & Greeks", "summary": "This article provides a detailed financial overview of Quanterix Corp (QTRX), including its stock performance, key financial metrics, and volatility data. It lists various ratios such as P/E, P/S, ROA, and highlights insider and institutional ownership, alongside short interest f", "url": "https://finviz.com/stock?t=QTRX&ty=ocv&p=d&r=ytd&ov=chain_date", "source_name": "Finviz", "published_at": "2026-06-26T05:10:55", "published_display": "26 Jun 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Stock Is Popping In Pre-Market: Here's Why", "summary": "Quanterix Corporation (NASDAQ: QTRX) stock surged 5.28% in pre-market trading after Securities and Exchange Commission filings revealed outgoing CFO Vandana Sriram vested and forfeited some restricted stock units. Jason Faessler officially assumed the CFO role, joining from Bruke", "url": "https://www.sahmcapital.com/news/content/quanterix-stock-is-popping-in-pre-market-heres-why-2026-06-24", "source_name": "Sahm", "published_at": "2026-06-25T15:39:37", "published_display": "25 Jun 2026 15:39", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Corp (QTRX) Valuation: PE, PB & Fair Value Analysis", "summary": "Quanterix Corp (QTRX) currently holds a valuation score of 7.38, placing it 163rd out of 203 in the Healthcare Equipment & Supplies industry. The company's P/E ratio is -1.83, which is significantly below its recent high and above its recent low. Key valuation metrics like P/B, P", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-qtrx/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-25T14:39:48", "published_display": "25 Jun 2026 14:39", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Corp sets out growth plans, shares trade on Nasdaq", "summary": "Quanterix Corp is gaining investor attention with its digital biomarker platform and recent operational milestones, with its shares trading on Nasdaq. The company focuses on developing ultra-sensitive digital biomarker assays based on its proprietary Simoa technology, targeting p", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/quanterix-corp-sets-out-growth-plans-shares-trade-on-nasdaq/69623587", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-25T12:41:48", "published_display": "25 Jun 2026 12:41", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Quanterix Corporation \u2013 NASDAQ:QTRX", "summary": "This article provides the \"Price to earnings forward\" metric for Quanterix Corporation (NASDAQ: QTRX). It indicates that the value and change percentages for this financial metric are made by humans and offers some context about the data providers. The main content focuses solely", "url": "https://www.tradingview.com/symbols/NASDAQ-QTRX/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-24T19:40:22", "published_display": "24 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) CFO adds stock as RSUs vest and shares withheld", "summary": "Quanterix CFO Vandana Sriram reported that 1,833 restricted stock units (RSUs) converted into common stock on June 15, 2026. Of these, 548 shares were withheld at $3.10 per share to cover tax obligations, which is a routine part of equity compensation. Following these transaction", "url": "https://www.stocktitan.net/sec-filings/QTRX/form-4-quanterix-corp-insider-trading-activity-ad0f6cb50692.html", "source_name": "Stock Titan", "published_at": "2026-06-24T14:39:48", "published_display": "24 Jun 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today", "summary": "Trinity Biotech (TRIB), Quanterix Corp. (QTRX), and Recon Technology (RCON) all experienced double-digit gains in after-hours trading. TRIB surged after launching Trinovium, a new subsidiary for liquid-cooling solutions for AI data centers. QTRX rose following the official appoin", "url": "https://stocktwits.com/news-articles/markets/equity/trib-qtrx-rcon-why-these-stocks-are-surging-after-hours-today/cZKUM3NR7O7", "source_name": "Stocktwits", "published_at": "2026-06-24T07:40:21", "published_display": "24 Jun 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Quanterix Corp For: 23 June", "summary": "This article provides an announcement regarding a Form 4 filing for Quanterix Corp on June 23. It also includes a standard disclaimer about the risks associated with trading financial instruments and cryptocurrencies, emphasizing market volatility and the importance of informed d", "url": "https://m.uk.investing.com/news/stock-market-news/form-4-quanterix-corp-for-23-june-93CH-4741296?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-24T01:40:25", "published_display": "24 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Quanterix Corp For: 23 June By Investing.com", "summary": "This article from Investing.com reports on a Form 4 filing for Quanterix Corp on June 23. It includes general stock market performance data for various indices, commodities, bonds, and individual stocks. The content indicates it's a routine financial news update on a company's SE", "url": "https://ca.investing.com/news/stock-market-news/form-4-quanterix-corp-for-23-june-93CH-4704252", "source_name": "Investing.com", "published_at": "2026-06-23T21:10:24", "published_display": "23 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/quanterix-corporation-reports-inducement-grants-200100131.html", "source_name": "Business Wire", "published_at": "2026-06-16T20:01:00+00:00", "published_display": "16 Jun 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) Chief Commercial Officer buys 3,500 shares in open-market trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNcEpBY1U5dkdJMzBQOUlLeGJvenBPTm44TWtRWkE1NG1LTXJrbUZ2RXFhMWFLU3ZzWHJOdE1ZSjFqMklmNkJzZDhTRmxqbWhGUGY0cGJQMmxYQzQxNkRSVF9kUmhsOTdZRk1ESTZteEJCUXdjOFROX1prM0lmTE53dl9HRU5Ia2tKRTNMMUpKNUtISEtkYl9WTnVVTGFnbnF3aHkyaWJoMzdUTXZu?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Names Jason Faessler as CFO", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/quanterix-names-jason-faessler-cfo-124406631.html", "source_name": "MT Newswires", "published_at": "2026-06-09T12:44:06+00:00", "published_display": "09 Jun 2026 12:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/quanterix-announces-appointment-jason-faessler-120300658.html", "source_name": "Business Wire", "published_at": "2026-06-09T12:03:00+00:00", "published_display": "09 Jun 2026 12:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "From Bruker to Quanterix: Jason Faessler takes over as CFO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNeWk5TXIzd1htQ3lMdlFxQ2x1aGZldko1dXFlLUk5VWdjaElPWXpoNGlYemhWV1FEVUpINWU1czQyVzNOR3NyUzNKM1dsOVJmZVdLc3Y3YU04dGo1X1JTc3hNVFZkSnBIdFRvajN2NU1DUGp0aXBRRlZFNl9Ob2hGZHF2WlNDRlMtTVZFb3RtZklScHNJREFKZG95NGFPWWoxNm9rV1F4UFJZU1NGLWZqLXNUb2VBS3lzTFZLLTFYRW0?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/quanterix-appoints-industry-veteran-geoff-120200262.html", "source_name": "Business Wire", "published_at": "2026-06-04T12:02:00+00:00", "published_display": "04 Jun 2026 12:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Former Quest exec Geoff Albrecht to lead Quanterix Alzheimer\u2019s diagnostics", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPNG5vaEI3MkhYN19hOVIxOFM1TjJKUG5BazkzQWFraW1MbmM1M3Z2dUMzbDQ3a25fNDJaaDBUa3RoZ0VkU25HZkJTRnFWdnhVTmlkZnptU0g5cmhqd0tjMFRGSDJaRVFTNm5qT25YZFFGb0ItV2U0RHBLcFFLcUROVjQ5VVNxNlp4VjVraHozTDQ1elIwd1plU09TdGxEdV8tU0IxWFpOU210ZmVSMTB2dG5FV0RETVYtRllSSg?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/quanterix-participate-goldman-sachs-47th-120100811.html", "source_name": "Business Wire", "published_at": "2026-06-03T12:01:00+00:00", "published_display": "03 Jun 2026 12:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix CEO to host June 9 fireside chat at Goldman Sachs healthcare event", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQV01DVkZTX0VnZW9Gc2pxaXBhVFg1b3RVWGc1NjQ2d09mZmJ0NWxaQ1FxMkloaXVGeGFzaXFnZERQTUpDenlBalAzY1RmbFFKdTllZ2Z6bGRxV1p2RncwOW5Ka1BvZkk1b2dReFl0YjRyZVN3UkZDRnpVZlVDaEtueXZXSzhnaXI2R1VPN1otblNTYlV5QldKWWpZTl95NVhEX3ItTkJIUjVPQV9SaWliZVVJWnpsbFpDaU93?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Quanterix COO Anthony Catalano gets 141,330 restricted stock units", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNZTd2VkFGdURFbTBsOHF2aG5jai1oR0pjUHNJb3A5MkhSeE1RQjZGUEJlVVFOSWViQlkwdDRFbzY0b25McURrWUhycDM2T0JadEpPTHRuY2FuS1RZQXdZVGZqYUlZcmZzSGxsRmtQQTVveDc0aXhoSnBHNzlHc0hhMkN6MHgtUl9KYmVpeVBnN0ZKdnM4Y2NoX3dUVkg3eGw3YkJ0ekxnWG9teWQwT20wV3pVYmlUbUJPaFBtR0RyYjA?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Says CFO Vandana Sriram to Depart", "summary": "", "url": "https://finance.yahoo.com/news/quanterix-says-cfo-vandana-sriram-204740297.html", "source_name": "MT Newswires", "published_at": "2026-05-12T20:47:40+00:00", "published_display": "12 May 2026 20:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix (QTRX) Q1 Loss Of US$0.37 Per Share Reinforces Bearish Profitability Concerns", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix partners with Tempus AI on Alzheimer\u2019s blood test", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOb05IeXhsakRkNXBfS3RkbWdSWWUyQW1fZmVTMFA5QTdXY1ZLSVc5UWRYRnhEZG9hcDUxcWEyNDlYVE1nWXVZV1BFOHdKZUN6cHQwU1FUQUo5dzczVEJXaV9ZWUcwS3ZFZWZ3a1c0enhoSU5rSVV4NHRfa0hGemkwejlkRWZjZ3p1eDZ1dHQ3U2RqU0JhMzZSS25ucXVZTWFDUHQwTHNvblY5cTVNSUdQNTI0eFlDUQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QUANTERIX ($QTRX) Releases Q1 2026 Earnings, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxORUtXRmRnVm1RVlU4S3ZSMU5FSzJLUm16aktSVDNxS2xpeVFiZy1wR0VCVUZMZEd4TXdZbkNtY1lUYnNXTi1OLWZwOVlTa09sR0wzamJhT0pFRHY5eE40cFhVOEJnc0I3QXhGOHdzNUFZekNnREdBUTdPV2tmWEc3X0h5TmxhZldHX19JblZRNXVVUXlGRWdXMkZGYXBqUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Q1 2026 slides: $85M synergies offset organic decline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPOEJkRTk5Rm4yTUhxZVlzeGIwQlVjZ1pZMTI1bVZ0bFYxNkNSZFQ1eWpNcm8xcEpubFRHZTVfUC13TldCdzZaeFFjR1lpNllWMlRVQ0FyNlRyRzRVaDFhcjdjcUQ1NVlsN1k1QkNPd0RqR3RsMDRBbHVHQjBVUkRRM0NYN25fQmItQXM1Z2ZuYUhSYWFROUZQYWo5cXNiTTg3RER3NlR6RzV1cmtERnByNnZ5X1c3a0w5N0E?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Quanterix (QTRX) Story Is Shifting After The Latest Fair Value Reset", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNNEVzOGltVGNrYS1jNVEydGtaeUZuMmQ4MERIVkFjaDQ3eG5ueUlSUlRJcS1XMnFOd1ZJUDc3eTJ0OTlIYnRQLXJ0dkdLSk1KMEZuUC1MTXVCMTlSYldBTU53YllEREJpaTJiMUZoNGdQRkM2Sk9HNGg4X1NEM21UNjRxMzZqVXA2d3NHNWJNMFFTaFNoS1RfQzRRc1premJ3TUJZ?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix: No Green Shoots (NASDAQ:QTRX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE91bFotNENIMXJkVXpYWjU4UEtOQ29iMDJ6Ukdzd2RrNXk3Qm1Zc1h0eU5pUTBGTDFzb2NicWxWUkFmZ0hIdlA5MmhYQjMyWndlZThWbjhGNlJoRGM2WUswZ0RLWUg2aEFybkhhWjhqYWxNLW5Z?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Corporation (QTRX) Reports Q4 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNR1RobkZ4VWJ0a01ZZ3Nocml0dXVUczkybWZiclZ0bndhZXJPUVBOdVp2bmdtaFZEYjRiakVjcS14TG5wR0gwVEdwRGpMX2RqVUFCS0VGQXlNMmZoOURMVlJ4aFc2OVMxWHBWcVNwYVhSUEhtN0lPbjc3Z1RaR2VrOVJaVDJJSW5QYkhR?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quanterix Corporation (QTRX) Stock Price Today: $3.87", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1IVFMzaDVGR2d1VUU0QUplWTZPMmNtTDZiMTl1cFBvanlTQ215Z2FOMTVDOEgxVUxOckF6SWZzY1o5YTNzSlVQMmxQblk0Q3l6T0FZSUhFOA?oc=5", "source_name": "Gotrade", "published_at": "2026-01-13T01:05:31+00:00", "published_display": "13 Jan 2026 01:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 92, "total_relevant": 62, "sentiment_summary": {"positive": 6, "negative": 7, "neutral": 49, "score": 51, "total": 62, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 22.7, "count": 40}, {"event": "earnings", "label": "Earnings", "weight": 9.49, "count": 20}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 7}, "market_context": {"has_market_context": true, "latest_close": 3.88, "latest_week": "2026-07-10", "one_week_move": -10.4, "four_week_move": 25.2, "twelve_week_move": 10.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.606468, "market_dynamics_buy_signal": false, "relative_strength": -35.468452, "fair_value_gap": -68.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 47.8179, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-10.4% over one week, +25.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 12}, {"label": "Stock Titan", "count": 11}, {"label": "Investing.com", "count": 5}, {"label": "Business Wire", "count": 5}, {"label": "TradingView", "count": 5}, {"label": "MT Newswires", "count": 3}, {"label": "Seeking Alpha", "count": 2}, {"label": "Quartr", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 51}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 40}, {"label": "Earnings", "count": 20}, {"label": "Regulatory and legal", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "51", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-10.4% over one week, +25.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Quanterix wins coverage for Alzheimer\u2019s test (QTRX:NASDAQ)"}], "updated_at": "2026-07-16T08:06:29.936398+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}